— ASEM: A Non‑Invasive Sensing Method Enabling Tissue Characterization —
ASEMtech Inc. (Headquartered in Koganei, Tokyo; Co‑CEOs: Kenji Ikushima and Nobuo Niimi; hereinafter “ASEMtech”), which aims to bring to society the Acoustically Stimulated Electromagnetic (ASEM) method—a novel ultrasound‑based technology that visualizes electrical and magnetic properties of biological tissues—has raised 150 million yen through a third‑party allotment in its Series A extension round completed in March 2026.
Combined with the 250 million yen raised in the initial Series A round conducted in April 2025, the company has now secured a total of 400 million yen across the entire Series A round.
Participants in this extension round include Hanno Shinkin Bank (Hanno Shinkin Regional Future Creation Fund), Tama Shinkin Bank (Tamashin Regional Future Co‑Creation Fund), BP Capital Inc. (TUAT No.1 Fund), and Leo Electronics Co., Ltd.
For more details, please click here.